Variant report
Variant | esv19391 |
---|---|
Chromosome Location | chr3:69881179-69884045 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs79658882 | chr3:69881186-69881187 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs144637254 | chr3:69881187-69881188 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs188356495 | chr3:69881197-69881198 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs9824528 | chr3:69881218-69881219 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs138460881 | chr3:69881255-69881256 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs9880541 | chr3:69881273-69881274 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs149396923 | chr3:69881305-69881306 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs546999910 | chr3:69881333-69881334 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs566982463 | chr3:69881349-69881350 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs575526372 | chr3:69881368-69881369 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs111596507 | chr3:69881405-69881406 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs62252182 | chr3:69881433-69881434 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs180871925 | chr3:69881440-69881441 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs568964508 | chr3:69881469-69881470 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs183757646 | chr3:69881473-69881474 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs9828924 | chr3:69881523-69881524 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs9825023 | chr3:69881536-69881537 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs9829056 | chr3:69881567-69881568 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs9881217 | chr3:69881726-69881727 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs112012655 | chr3:69881770-69881771 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs532652041 | chr3:69881802-69881803 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs386662131 | chr3:69881840-69881841 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs115218797 | chr3:69881841-69881842 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs34162170 | chr3:69881853-69881854 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs62252216 | chr3:69881906-69881907 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs556183646 | chr3:69881916-69881917 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs575753674 | chr3:69881965-69881966 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs189147277 | chr3:69881980-69881981 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs143773520 | chr3:69881989-69881990 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs530394156 | chr3:69881997-69881998 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs182487966 | chr3:69882057-69882058 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs187142458 | chr3:69882072-69882073 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs191952645 | chr3:69882081-69882082 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs560275246 | chr3:69882090-69882091 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs532494064 | chr3:69882098-69882099 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs552391737 | chr3:69882099-69882100 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs569308789 | chr3:69882113-69882114 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs531420686 | chr3:69882114-69882115 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs547967985 | chr3:69882133-69882134 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs568043136 | chr3:69882137-69882138 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs148150167 | chr3:69882177-69882178 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs372568088 | chr3:69882195-69882196 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs570361913 | chr3:69882207-69882208 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs144074161 | chr3:69882219-69882220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs556000506 | chr3:69882263-69882264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs576188984 | chr3:69882277-69882278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs538467338 | chr3:69882281-69882282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs555197693 | chr3:69882295-69882296 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs575246855 | chr3:69882306-69882307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs540935097 | chr3:69882308-69882309 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16608533 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Metastatic melanoma | 17975146 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 22102821 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 21062444 | CNVD |
Prostate cancer | 17217626 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Mental retardation | 20848658 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Malignant glioma | 16001072 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Mental retardation | 17847001 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:69870200-69886000 | Weak transcription | Aorta | Aorta |
2 | chr3:69870600-69886200 | Weak transcription | Colon Smooth Muscle | Colon |
3 | chr3:69873800-69887600 | Weak transcription | NHLF | lung |
4 | chr3:69876400-69881200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr3:69879400-69881800 | Weak transcription | Fetal Heart | heart |
6 | chr3:69879600-69884200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
7 | chr3:69879600-69886000 | Weak transcription | Right Atrium | heart |
8 | chr3:69879600-69886000 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
9 | chr3:69881000-69881200 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
10 | chr3:69881000-69881200 | Genic enhancers | Ovary | ovary |
11 | chr3:69881000-69881200 | Enhancers | Pancreas | Pancrea |
12 | chr3:69881000-69881200 | Enhancers | K562 | blood |
13 | chr3:69881000-69881400 | Enhancers | Brain Hippocampus Middle | brain |
14 | chr3:69881000-69881400 | Enhancers | Left Ventricle | heart |
15 | chr3:69881000-69881600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
16 | chr3:69881000-69881600 | Enhancers | Psoas Muscle | Psoas |
17 | chr3:69881000-69881600 | Enhancers | Right Ventricle | heart |
18 | chr3:69881200-69881400 | Enhancers | Ovary | ovary |
19 | chr3:69881200-69886200 | Weak transcription | K562 | blood |
20 | chr3:69881400-69886000 | Weak transcription | Left Ventricle | heart |
21 | chr3:69881400-69886000 | Weak transcription | Ovary | ovary |
22 | chr3:69881600-69885600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
23 | chr3:69881600-69886000 | Weak transcription | Right Ventricle | heart |
24 | chr3:69881800-69882200 | Enhancers | Fetal Heart | heart |